Global In Vivo Imaging Systems Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global In Vivo Imaging Systems market size was valued at US$ 137 million in 2024 and is forecast to a readjusted size of USD 169 million by 2031 with a CAGR of 3.0% during review period.

Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

Small animal in vivo imaging technology is a non-invasive method widely used in biomedical research, which can observe and track biological processes in small animals in real time. Through this technology, researchers can gain a deep understanding of dynamic changes such as disease progression, drug response and gene expression. Common in vivo imaging technologies include optical imaging, magnetic resonance imaging (MRI), positron emission tomography (PET), etc. This technology helps to reduce the use of experimental animals, provide more efficient and accurate experimental data, and promote the development of new drugs and the study of disease mechanisms. The main manufacturers of small animal in vivo imaging systems (In Vivo Imaging Systems) in the world include Perkin Elmer, Canon Medical Systems, Bruker, Idexx Laboratories and Hallmarq Veterinary Imaging, etc. The top five manufacturers account for about 47% of the global market share. In terms of revenue, North America is the largest market, accounting for about 64% of the market share. In terms of product type, optical imaging is the largest segment, accounting for about 65% of the revenue share, and in terms of downstream, laboratories are the largest downstream field, accounting for 78% of the revenue share. In the small animal in vivo imaging industry, manufacturers need to take multiple measures to promote technological innovation and enhance market competitiveness. First, manufacturers should focus on technology research and development, and continuously improve the resolution, sensitivity and multimodal functions of imaging equipment so that they can more accurately capture biological processes in small animals. In addition, manufacturers should focus on developing user-friendly software platforms to ensure the automation and simplicity of data acquisition and analysis to reduce the operational burden of researchers and improve experimental efficiency. Secondly, manufacturers should strengthen cooperation with scientific research institutions and pharmaceutical companies to meet the needs of different industries and fields through customized solutions. For example, in cutting-edge fields such as cancer research, new drug development and gene therapy, providing targeted imaging equipment and services can effectively expand the market. At the same time, manufacturers should also pay attention to the cost-effectiveness of equipment, while maintaining high-quality imaging performance, by optimizing production processes and supply chains, reducing the manufacturing cost of equipment, making in vivo imaging technology more economically feasible, and attracting more small and medium-sized laboratories to use it. In addition, with the increasing global attention to animal welfare, manufacturers also need to ensure that their equipment complies with ethical standards and regulations, reduce unnecessary harm to experimental animals, and provide more accurate non-invasive imaging technology to help researchers achieve more humane experimental design. Finally, manufacturers should establish a comprehensive after-sales service system to provide equipment maintenance, technical support and operation training to ensure that users can use the equipment in a long-term and stable manner. Through a comprehensive layout in technology, cooperation, cost, ethics and service, manufacturers can maintain a sustained competitive advantage in the small animal in vivo imaging industry, meet the growing needs of scientific researchers and pharmaceutical companies, and promote the advancement of biomedical research.

This report is a detailed and comprehensive analysis for global In Vivo Imaging Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global In Vivo Imaging Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031

Global In Vivo Imaging Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031

Global In Vivo Imaging Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031

Global In Vivo Imaging Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K USD/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for In Vivo Imaging Systems

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global In Vivo Imaging Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Perkin Elmer, Canon Medical Systems, Bruker, Idexx Laboratories, Hallmarq Veterinary Imaging, Huantong Nuclear Magnet, Sunny Optical, Photon, MILABS, iThera Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

In Vivo Imaging Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Optical Imaging
MRI
Ultrasound
Others

Market segment by Application
Laboratory
Pet Hospital and Clinic

Major players covered
Perkin Elmer
Canon Medical Systems
Bruker
Idexx Laboratories
Hallmarq Veterinary Imaging
Huantong Nuclear Magnet
Sunny Optical
Photon
MILABS
iThera Medical
Vieworks
Aspect Imaging
TOMOWAVE
Trifoil Imaging
Clinx
Raylight
Spectral Instruments Imaging
Novel Medical
Tanon
Biolight
PINGSENG Healthcare
Fujifilm Visualsonics

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe In Vivo Imaging Systems product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of In Vivo Imaging Systems, with price, sales quantity, revenue, and global market share of In Vivo Imaging Systems from 2020 to 2025.

Chapter 3, the In Vivo Imaging Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the In Vivo Imaging Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and In Vivo Imaging Systems market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of In Vivo Imaging Systems.

Chapter 14 and 15, to describe In Vivo Imaging Systems sales channel, distributors, customers, research findings and conclusion.